Health Highlights: Aug. 8, 2019
Here are some of the latest health and medical news developments, compiled by the editors of HealthDay:
Medicare to Cover Breakthrough Gene Therapy for Leukemia, Lymphoma
A breakthrough gene therapy will be covered for certain types of lymphoma and leukemia, Medicare says.
The therapy, called CAR-T, boosts a patient's own immune cells to fight cancer and can cost hundreds of thousands of dollars, the Associated Press reported.
Studies have shown that CAR-T is effective against certain types of cancers, but can cause severe side effects. The use of the gene therapy to treat certain types of leukemia and lymphoma is approved by the U.S. Food and Drug Administration.
Medicare considered the matter for months before it announced its decision on Wednesday. The agency's policies on coverage can influence private insurance, the AP reported.
The news stories provided in Health News and our Health-E News Newsletter are a service of the nationally syndicated HealthDay® news and information company. Stories refer to national trends and breaking health news, and are not necessarily indicative of or always supported by our facility and providers. This information is provided for informational and educational purposes only, and is not intended to be a substitute for medical advice, diagnosis, or treatment.